Axsome Therapeutics, Inc. (AXSM) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Axsome Therapeutics, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AXSM vs OSCR

growth of $100 · dividends reinvested · last 6y
AXSM +155.9% (+17.0%/yr)OSCR -6.8% (-1.2%/yr)AXSM compounded faster over this window
0100200300Start $10020222023202420252026$256$93
AXSM OSCR

AXSM vs OSCR: by the numbers

  • •AXSM is the larger company ($9.11B vs $8.41B market cap).
  • •OSCR is profitable (3.60% net margin) while AXSM runs a net loss (-24.68%).

Metrics side by side

Valuation

MetricAXSMOSCR
P/E ratioN/A23.16
Forward P/EN/A16.98
P/S ratio11.730.55
P/B ratio109.394.10
EV / EBITDAN/A7.30
FCF yieldN/A51.57%

Profitability

MetricAXSMOSCR
Gross margin93.24%14.38%
Operating margin-24.28%4.07%
Net margin-24.68%3.60%
ROE-230.05%26.84%
ROIC-50.82%22.98%

Growth (annualized)

MetricAXSMOSCR
Revenue CAGR (5Y)N/A64.83%
FCF CAGR (5Y)N/A80.81%
Total return CAGR (5Y)41.40%14.97%

Frequently asked

Is AXSM or OSCR more profitable?
OSCR runs the higher net margin — AXSM at -24.68% versus OSCR at 3.60%.
How have AXSM and OSCR total returns compared?
Over the past 5 years, AXSM delivered 41.40% and OSCR delivered 14.97% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.